161 related articles for article (PubMed ID: 20408955)
1. Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases.
Van Keimpema L; De Koning DB; Van Hoek B; Van Den Berg AP; Van Oijen MG; De Man RA; Nevens F; Drenth JP
Liver Int; 2011 Jan; 31(1):92-8. PubMed ID: 20408955
[TBL] [Abstract][Full Text] [Related]
2. Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease.
Waanders E; te Morsche RH; de Man RA; Jansen JB; Drenth JP
Hum Mutat; 2006 Aug; 27(8):830. PubMed ID: 16835903
[TBL] [Abstract][Full Text] [Related]
3. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.
Hoevenaren IA; Wester R; Schrier RW; McFann K; Doctor RB; Drenth JP; Everson GT
Liver Int; 2008 Feb; 28(2):264-70. PubMed ID: 17927714
[TBL] [Abstract][Full Text] [Related]
4. Polycystic liver disease is a disorder of cotranslational protein processing.
Drenth JP; Martina JA; van de Kerkhof R; Bonifacino JS; Jansen JB
Trends Mol Med; 2005 Jan; 11(1):37-42. PubMed ID: 15649821
[TBL] [Abstract][Full Text] [Related]
5. Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease.
Drenth JP; Tahvanainen E; te Morsche RH; Tahvanainen P; Kääriäinen H; Höckerstedt K; van de Kamp JM; Breuning MH; Jansen JB
Hepatology; 2004 Apr; 39(4):924-31. PubMed ID: 15057895
[TBL] [Abstract][Full Text] [Related]
6. Secondary, somatic mutations might promote cyst formation in patients with autosomal dominant polycystic liver disease.
Janssen MJ; Waanders E; Te Morsche RH; Xing R; Dijkman HB; Woudenberg J; Drenth JP
Gastroenterology; 2011 Dec; 141(6):2056-2063.e2. PubMed ID: 21856269
[TBL] [Abstract][Full Text] [Related]
7. Hepatocystin is not secreted in cyst fluid of hepatocystin mutant polycystic liver patients.
Waanders E; Lameris AL; Op den Camp HJ; Pluk W; Gloerich J; Strijk SP; Drenth JP
J Proteome Res; 2008 Jun; 7(6):2490-5. PubMed ID: 18419150
[TBL] [Abstract][Full Text] [Related]
8. Somatic second-hit mutations leads to polycystic liver diseases.
Banales JM; Munoz-Garrido P; Bujanda L
World J Gastroenterol; 2013 Jan; 19(1):141-3. PubMed ID: 23326178
[TBL] [Abstract][Full Text] [Related]
9. What the similarities of specific polycystic liver and kidney diseases can teach us about both.
Hogan MC; Torres VE
Nephrol News Issues; 2008 Aug; 22(9):29-31. PubMed ID: 18778002
[No Abstract] [Full Text] [Related]
10. Polycystic liver and kidney diseases.
Tahvanainen E; Tahvanainen P; Kääriäinen H; Höckerstedt K
Ann Med; 2005; 37(8):546-55. PubMed ID: 16338757
[TBL] [Abstract][Full Text] [Related]
11. Cysts of PRKCSH mutated polycystic liver disease patients lack hepatocystin but express Sec63p.
Waanders E; Croes HJ; Maass CN; te Morsche RH; van Geffen HJ; van Krieken JH; Fransen JA; Drenth JP
Histochem Cell Biol; 2008 Mar; 129(3):301-10. PubMed ID: 18224332
[TBL] [Abstract][Full Text] [Related]
12. Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease.
Drenth JP; te Morsche RH; Smink R; Bonifacino JS; Jansen JB
Nat Genet; 2003 Mar; 33(3):345-7. PubMed ID: 12577059
[TBL] [Abstract][Full Text] [Related]
13. Hepatobiliary abnormalities and disease in cystic fibrosis: epidemiology and outcomes through adulthood.
Bhardwaj S; Canlas K; Kahi C; Temkit M; Molleston J; Ober M; Howenstine M; Kwo PY
J Clin Gastroenterol; 2009 Oct; 43(9):858-64. PubMed ID: 19525864
[TBL] [Abstract][Full Text] [Related]
14. Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study.
van Keimpema L; Nevens F; Adam R; Porte RJ; Fikatas P; Becker T; Kirkegaard P; Metselaar HJ; Drenth JP;
Transpl Int; 2011 Dec; 24(12):1239-45. PubMed ID: 21955068
[TBL] [Abstract][Full Text] [Related]
15. Isolated polycystic liver disease genes define effectors of polycystin-1 function.
Besse W; Dong K; Choi J; Punia S; Fedeles SV; Choi M; Gallagher AR; Huang EB; Gulati A; Knight J; Mane S; Tahvanainen E; Tahvanainen P; Sanna-Cherchi S; Lifton RP; Watnick T; Pei YP; Torres VE; Somlo S
J Clin Invest; 2017 May; 127(5):1772-1785. PubMed ID: 28375157
[TBL] [Abstract][Full Text] [Related]
16. Boy with autosomal recessive polycystic kidney and autosomal dominant polycystic liver disease.
Zingg-Schenk A; Caduff J; Azzarello-Burri S; Bergmann C; Drenth JP; Neuhaus TJ
Pediatr Nephrol; 2012 Jul; 27(7):1197-200. PubMed ID: 22415584
[TBL] [Abstract][Full Text] [Related]
17. Advances in management of polycystic liver disease.
Everson GT; Helmke SM; Doctor B
Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):563-76. PubMed ID: 19072404
[TBL] [Abstract][Full Text] [Related]
18. Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease.
Schönauer R; Sierks D; Boerrigter M; Jawaid T; Caroff L; Audrezet MP; Friedrich A; Shaw M; Degenhardt J; Forberger M; de Fallois J; Bläker H; Bergmann C; Gödiker J; Schindler P; Schlevogt B; Müller RU; Berg T; Patterson I; Griffiths WJ; Sayer JA; ; Popp B; Torres VE; Hogan MC; Somlo S; Watnick TJ; Nevens F; Besse W; Cornec-Le Gall E; Harris PC; Drenth JPH; Halbritter J
Gastroenterology; 2024 May; 166(5):902-914. PubMed ID: 38101549
[TBL] [Abstract][Full Text] [Related]
19. Multiple cysts in the liver autosomal dominant polycystic liver disease.
Karimbeg AA; Loffeld RJ
Neth J Med; 2006 Jun; 64(6):199-201. PubMed ID: 16788219
[TBL] [Abstract][Full Text] [Related]
20. Does model for end-stage liver disease score predict the short-term outcome of living donor liver transplantation?
Li C; Wen T; Yan L; Li B; Wang W; Xu M; Yang J; Wei Y
Transplant Proc; 2010 Nov; 42(9):3620-3. PubMed ID: 21094827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
